Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piers Blombery

Showing results (31-40 of 157) with videos related to

Pageof 16
Sort By:
Leukemia & Lymphoma|August 10, 2017
Comprehensive genomic characterization dissects the complex biology of a case of synchronous Burkitt lymphoma and myeloid malignancy with shared hematopoietic ancestryGeorgina L Ryland, Kate Jones, Michelle McBean, et al.
Pathology|March 9, 2021
CAR-T cell therapy: practical guide to routine laboratory monitoringAdrian G Selim, Adrian Minson, Piers Blombery, et al.
The Australasian Journal of Dermatology|May 26, 2026
A Case of Primary Cutaneous BRAF<sup>V600E+</sup> Langerhans Cell Histiocytosis, With Underlying Chronic Myelomonocytic Leukaemia, Responsive to Dabrafenib With Subsequent Undetectable Circulating Cell Free DNAKate Simpson, Friyana Bhabha, Alicia Snowden, et al.
Pathology|September 24, 2022
Clinically relevant variation in FLT3-ITD quantitation as a result of PCR cycle number and ITD insertion sizeIng S Tiong, Nikky Andrieska, Phuong Dang, et al.
British Journal of Haematology|February 10, 2025
Serial sensitive molecular detection of JAK2 V617F is predictive of relapse after allogeneic stem cell transplantation in patients with myelofibrosisRithin Nedumannil, Tal Karmi, Piers Blombery, et al.
Pathology|February 27, 2024
Observations from a national sample exchange program for molecular haematology testingClare Gould, Michelle McBean, Ella Thompson, et al.
Pathology|June 2, 2026
Myeloid/lymphoid neoplasms with eosinophilia and ZMYM2::FLT3 fusion: clinical, pathological and molecular clues to a cryptic diagnosisImogen Caldwell, Samuel Grigg, Leanne Berkahn, et al.
Leukemia & Lymphoma|September 4, 2024
Chronic lymphocytic leukemia with <i>MDM2</i> amplification as an alternative pathway to TP53 dysfunctionSally Hunter, Georgina Ryland, Jia-Min Pang, et al.
British Journal of Haematology|April 13, 2023
Computational flow cytometry provides accurate assessment of measurable residual disease in chronic lymphocytic leukaemiaPhillip C Nguyen, Vuong Nguyen, Kylie Baldwin, et al.
Archives of Pathology & Laboratory Medicine|February 10, 2018
Sensitive NPM1 Mutation Quantitation in Acute Myeloid Leukemia Using Ultradeep Next-Generation Sequencing in the Diagnostic LaboratoryPiers Blombery, Kate Jones, Ken Doig, et al.
Pageof 16

Showing results (31-40 of 157) with videos related to

Sort By:
Pageof 16
Leukemia & Lymphoma|August 10, 2017
Comprehensive genomic characterization dissects the complex biology of a case of synchronous Burkitt lymphoma and myeloid malignancy with shared hematopoietic ancestryGeorgina L Ryland, Kate Jones, Michelle McBean, et al.
Pathology|March 9, 2021
CAR-T cell therapy: practical guide to routine laboratory monitoringAdrian G Selim, Adrian Minson, Piers Blombery, et al.
The Australasian Journal of Dermatology|May 26, 2026
A Case of Primary Cutaneous BRAF<sup>V600E+</sup> Langerhans Cell Histiocytosis, With Underlying Chronic Myelomonocytic Leukaemia, Responsive to Dabrafenib With Subsequent Undetectable Circulating Cell Free DNAKate Simpson, Friyana Bhabha, Alicia Snowden, et al.
Pathology|September 24, 2022
Clinically relevant variation in FLT3-ITD quantitation as a result of PCR cycle number and ITD insertion sizeIng S Tiong, Nikky Andrieska, Phuong Dang, et al.
British Journal of Haematology|February 10, 2025
Serial sensitive molecular detection of JAK2 V617F is predictive of relapse after allogeneic stem cell transplantation in patients with myelofibrosisRithin Nedumannil, Tal Karmi, Piers Blombery, et al.
Pathology|February 27, 2024
Observations from a national sample exchange program for molecular haematology testingClare Gould, Michelle McBean, Ella Thompson, et al.
Pathology|June 2, 2026
Myeloid/lymphoid neoplasms with eosinophilia and ZMYM2::FLT3 fusion: clinical, pathological and molecular clues to a cryptic diagnosisImogen Caldwell, Samuel Grigg, Leanne Berkahn, et al.
Leukemia & Lymphoma|September 4, 2024
Chronic lymphocytic leukemia with <i>MDM2</i> amplification as an alternative pathway to TP53 dysfunctionSally Hunter, Georgina Ryland, Jia-Min Pang, et al.
British Journal of Haematology|April 13, 2023
Computational flow cytometry provides accurate assessment of measurable residual disease in chronic lymphocytic leukaemiaPhillip C Nguyen, Vuong Nguyen, Kylie Baldwin, et al.
Archives of Pathology & Laboratory Medicine|February 10, 2018
Sensitive NPM1 Mutation Quantitation in Acute Myeloid Leukemia Using Ultradeep Next-Generation Sequencing in the Diagnostic LaboratoryPiers Blombery, Kate Jones, Ken Doig, et al.
Pageof 16